This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.

This study aims to assess the current evidence on photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions).

1 Guidance

1.1 Current evidence suggests that there are no major safety concerns associated with photodynamic therapy for non-melanoma skin tumours (including premalignant and primary nonmetastatic skin lesions).

1.2 Evidence of efficacy of this procedure for the treatment of basal cell carcinoma, Bowen's disease and actinic (solar) keratosis is adequate to support its use for these conditions, provided that the normal arrangements are in place for consent, audit and clinical governance.

1.3 Evidence is limited on the efficacy of this procedure for the treatment of invasive squamous cell carcinoma. Recurrence rates are high and there is a risk of metastasis. Clinicians should ensure that patients understand these risks and that retreatment may be necessary. In addition, use of the Institute's Information for the public is recommended (available from www.nice.org.uk/IPG155publicinfo).